OHSU spinout raised $1.5M for cancer drug platform

An Oregon Health& Science University spinout raised $1.5 million, which will help advance its cancer drug candidate toward a clinical trial. PDX Pharmaceuticals received the Series A funding from The Wayne D. Kuni& Joan E. Kuni Foundation, based in Vancouver. The funding is part of a $4 million offering, according to a filing with the U.S. Securities& Exchange Commission. PDX Pharmaceuticals’ first drug candidate is targeted for treatment of HER2-positive breast cancer, which accounts for…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news